hat
Q uinine HCL gen yon avantaj diferan sou lòt antimalarials: byenke li se chè ak tan konsome yo pwodwi, parazit yo ki lakòz malarya parèt yo dwe ralanti yo devlope yon rezistans nan li. Kòm yon rezilta, li se pafwa itilize pou trete medikaman rezistan malarya, nan plas medikaman ki ka fail nan travay. Malgre ke li te sentèz istorikman, chèchè yo poko pafè yon pwosesis sentèz efikas ak egzat pou medikaman an, se konsa, pou kounye a, li kontinye ap pwodui nan fason tradisyonèl la.
eng
Quinine HCL has a distinct advantage over other antimalarials: although it is expensive and time consuming to produce, the parasites that cause malaria appear to be slow to develop a resistance to it. As a result, it is sometimes used to treat medicine resistant malaria, in lieu of medications which may fail to work. Although it has been synthesized historically, researchers have yet to perfect an efficient and accurate synthesis process for the medicine, so, for now, it continues to be produced in the traditional way.